Preparation and in vivo evaluation of self-nanoemulsifying drug delivery system (SNEDDS) containing ezetimibe

Current Nanoscience

Volumn 7, Issue 4, 2011, Pages 616-627

  Dabhi, Mahesh R ^a   Limbani, Milan D ^a   Sheth, Navin R ^a  

^a SAURASHTRA UNIVERSITY   (India)

Author keywords

Ezetimibe; Globule size; Hyperlipidemia; Self nanoemulsifying drug delivery system (snedds); Simplex lattice design

Indexed keywords

EZETIMIBE; GLOBULE SIZE; HYPERLIPIDEMIA; SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS); SIMPLEX-LATTICE DESIGN;

BIOCHEMISTRY; EMULSIFICATION; OLEIC ACID; OPTIMIZATION; PHASE DIAGRAMS; REGRESSION ANALYSIS; SURFACE ACTIVE AGENTS;

DRUG DELIVERY;

COSURFACTANT; EZETIMIBE; MACROGOL 400; OLEIC ACID; SURFACTANT; WATER;

ARTICLE; DILUTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DIFFUSION; DRUG FORMULATION; DRUG MARKETING; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; EMULSION; FAMILIAL HYPERCHOLESTEROLEMIA; HOMOZYGOUS SITOSTEROLEMIA; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; ROOM TEMPERATURE; SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM;

RATTUS;

EID: 79959991681     PISSN: 15734137     EISSN: 18756786     Source Type: Journal    
DOI: 10.2174/157341311796196853     Document Type: Article

References (51)

1. Burcham, D.L.; Maurin, M.B.; Hausner, E.A.; Huang, S.M. Improved oral bioavailability of the hypocholesterolemic DMP 565 in dogs following oral dosing in oil and glycol solutions. Biopharm. Drug. Dispos., 1997, 18, 737-742.
2. Serajuddin, A.T.M.; Sheen, P.C.; Mufson, D.; Bernstein, D.F.; Augustine, M.A. Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersion. J. Pharm. Sci., 1988, 77, 414-417.
3. Myers, R.A.; Stella, V.J. Systemic bioavailability of penclomedine (NSC-338720) from oil- in-water emulsions administered intraduodenally to rats. Int. J. Pharm., 1992, 78, 217-226.
4. Jumaa, M.; Furkert, F.H.; Muller, B.W. A new lipid emulsion formulation with high antimicrobial efficacy using chitosan. Eur. J. Pharm. Biopharm., 2002, 53, 115-123.
5. Schwendener, R.A.; Schott, H. Lipophilic 1-beta-d-arabino-furanosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model. J. Cancer Res. Clin. Oncol., 1996, 122, 723-726.
6. Sheikh, S.; Shakeel, F.; Talegaonkar, S.; Ahmad, F.J.; Khar, R.K.; Ali, M. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm., 2007, 66, 227-243.
7. Taha, E.I.; Al-Saidan, S.; Samy, A.M.; Khana, M.A. Preparation and in vitro characterization of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Int. J. Pharm., 2004, 285, 109-119.
8. Wu, W.; Wang, Y.; Que, L. Enhanced bioavailability of silymarin by self microemulsifying drug delivery system. Eur. J. Pharm. Biopharm., 2006, 63, 288-294.
9. Charman, S.A.; Charman, W.N.; Rogge, M.C.; Wilson, T.D.; Pouton, C.W. Self-emulsifying drug delivery systems: formulation and biopharmaceutical evaluation of an investigational lipophilic compound. Pharm. Res., 1992, 9, 83-87.
10. Pouton, C.W. SEDDS: Assessment of the efficiency of emulsification. Int. J. Pharm., 1985, 27, 335-348.
11. Faiyaz, S.; Wafa, R.; Mohammed, S.; Faisal, M.; Rizwan, M.; Faiyazuddin, GM.; Sheikh, S. Transdermal and topical delivery of anti-inflammatory agents using nanoemulsion/microemulsion: an updated review. Curr. Nanosci., 2010, 6(2), 184-198.
12. Lawrence, M.J.; Rees, G.D. Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev., 2000, 45, 89-121.
13. Prince, L.M. Schulman's microemulsions. Prince, L.M. (Ed.) In: Microemulsions theory and practice. Academic Press: New York, 1977, pp. 1-20.
14. Maria, L.B.; Antonina, A.; Emanuela, F.C.; Giulia, C.; Nadia, L.; Gaetano, G.; Melchiorre, C. Solid lipid nanoparticles containing nimesulide: preparation, characterization and cytotoxicity studies. Curr. Nanosci., 2009, 5, 39-44.
15. Charman, S.A.; Charman, W.N.; Rogge, M.C.; Wilson, T.D.; Dutko, F.J.; Pouton, C.W. Self-emulsifying drug delivery systems: Formulation and biopharmaceutical evaluation of an investigational lipophilic compound. Pharm. Res., 1992, 9, 87-93.
16. Shah, N.H.; Carvajal, M.T.; Patel, C.I.; Infeld, M.H.; Malick, A.W. Selfemulsifying drug delivery systems (SEDDS) with polyglycolysed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int. J. Pharm., 1994, 106, 15-23.
17. Konstantinos, G.; Konstantinos, D.; Aristidis, G.; Eleni, K.; Stergios, P.; Costas, D. β-lactam Functionalized Poly(Isoprene-B-Ethylene Oxide) Amphiphilic Block Copolymer Micelles as a New Nanocarrier System for Curcumin. Curr. Nanosci., 2010, 6(3), 277-284.
18. Khoo, S.H.; Humberstone, A.J.; Porter, C.J.H.; Edwards, G.A.; Charman, W.N. Formulation design and bioavailability assessment of lipidic selfemulsifying formulations of halofantrine. Int. J. Pharm., 1998, 167, 155-164.
19. Julianto, T.; Yuen, K.H.; Noor, A.M. Improved bioavailability of vitamin E with a self emulsifying formulation. Int. J. Pharm., 2000, 200, 53-57.
20. Kommuru, T.R.; Gurley, B.; Khan, M.A.; Reddy, I.K. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int. J. Pharm., 2001, 212, 233-246.
21. Gao, Z.G.; Choi, H.G.; Shin, H.J. Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporine A. Int. J. Pharm., 1998, 161, 75-86.
22. Kim, H.J.; Yoon, K.A.; Hahn, M.; Park, E.S.; Chi, S.C. Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Dev. Ind. Pharm., 2000, 26, 523-529.
23. Gulam, M.; Zeenat, K.; Tripta, B.; Sushama, T. Preparation and characterization of oil in water nano-reservoir systems for improved oral delivery of Atorvastatin. Curr. Nanosci., 2009, 5, 428-440.
24. Wen-zhi, Y.; Hong-li, C.; Fu-ping, G.; Min-mao, C.; Xue-min, L.; Mingming, Z.; Qi-qing, Z.; Ling-rong, L.; Qian, J.; Yin-song, W. Self-aggregated nanoparticles of cholesterol-modified pullulan conjugate as a novel carrier of Mitoxantrone. Curr. Nanosci., 2010, 6(3), 298-306.
25. Bondì, M.; Montana, G.; Craparo, E.; Picone, P.; Capuano, G.; Di-Carlo, M.; Giammonas G. Ferulic Acid-Loaded lipid nanostructures as drug delivery systems for Alzheimer's Disease: Preparation, characterization and cytotoxicity studies. Curr. Nanosci., 2009, 5, 26-32.
26. Xiaohui, P.; Jin, S.; Mo, L.; Zhonggui, H. Formulation of nanosuspensions as a new approach for the delivery of poorly soluble drugs. Curr. Nanosci., 2009, 5, 417-427.
27. Jumaa, M.; Kleinebudde, P.; Muller, B.W. Mixture experiments with the oil phase of parenteral emulsions. Eur. J. Pharm. Biopharm., 1998, 46, 161-167.
28. Subramanian, N.; Ray, S.; Ghosal, S.K.; Bhadra, R.; Moulik, S.P. Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biol. Pharm. Bull., 2004, 27, 1993-1999.
29. Li, H.; Pan, W.S.; Li, J.Y. Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery. Drug Dev. Ind. Pharm., 2004, 30, 657-666.
30. Li, H.; Pan, W.S.; Wu, Z.; Li, J.Y.; Xia, L.X. Optimization of microemulsion containing vinpocetine and its physicochemical properties. Yao Xue Xue Bao, 2004, 39, 681-685.
31. Ho, H.O.; Huang, F.C.; Sokoloski, T.D.; Sheu, M.T. The influence of cosolvents on the in vitro percutaneous penetration of diclofenac sodium from a gel system. J. Pharm. Pharmacol., 1994, 46, 636-642.
32. Hong, W.; Wu, C.Z. Experiment design and analysis-principles, operation and cases. China Forestry Press: Beijing, 2004.
33. Mao, S.S.; Zhou, J.X.; Chen, Y. Design of experiment. China Statistics Press: Beijing, 2004.
34. Ren, L.Q. Optimum design and analysis of experiments. 2nd ed. High Education Press: Beijing, 2003.
35. Dalmora, S.L.; Oliveria, P.R.; Brum, L.; Fronza, M. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ezetimibe in human plasma and pharmaceutical formulations. Chromatographia, 2006, 63, 315-320.
36. Sistla, R.; Tata, V.S.; Kashyap, Y.V.; Chandrashekhar, D.; Diwan, P.V. Development and validation of a reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage forms. J. Pharm. Biomed. Anal., 2005, 39, 157.
37. Zhi-gang, F.; Ping, P.; Zhi-qiang, Y.; Ya-gen, C.; Jian-kang, Z.; Miao, W.; Xue-nong, Z.; Zhang, Q. Two Novel Freeze-Dried pH-Sensitive Cyclosporine A Nanoparticles: Preparation, in vitro Drug Release, and in vivo Absorption Enhancement Effects. Curr. Nanosci., 2009, 5, 449-456.
38. Constantinides, P.P. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res., 1995, 12, 1561-1572.
39. Klous, M.G.; Nuijen, B.; Vanden, B.W.; Vanree, J.M.; Beijnen, J.H. Process characterisation, optimisation and validation of production of diacetylmorphine/ caffeine sachets: a design of experiments approach. Int. J. Pharm., 2004, 285, 65-75.
40. Craig, D.Q.M.; Barker, S.A.; Banning, D.; Booth, S.W. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int. J. Pharm., 1995, 114, 103-110.
41. Zhang, Q.Z.; Jiang, X.G.; Jiang, W.M.; Lu, W.; Su, L.N.; Shi, Z.Q. Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain. Int. J. Pharm., 2004, 275, 85-96.
42. Gershanik, T.; Benita, S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur. J. Pharm. Biopharm., 2000, 50, 179-188.
43. Kang, B.K.; Lee, J.S.; Chon, S.K.; Jeong, S.Y.; Yuk, S.H.; Khang, G.; Lee, H.B.; Cho, S.H. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int. J. Pharm., 2005, 274, 65-73.
44. Pouton, C.W. Lipid formulations for oral administration of drugs: nonemulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur. J. Pharm. Sci., 2000, 11, S93-S98.
45. Gershanik, T.; Haltner, E.; Lehr, C.M.; Benita, S. Charge-dependent interaction of self-emulsifying oil formulations with Caco-2 cells monolayers: binding, effects on barrier function and cytotoxicity. Int. J. Pharm., 2000, 211, 29-36.
46. Wei, L.L.; Sun, P.N.; Nie, S.F.; Pan, W.S. Preparation and evaluation of SEDDS and SMEDDS containing Carvedilol. Drug Dev. Ind. Pharm., 2005, 31, 785-794.
47. Ruth, H.S.; Attwood, D.; Ktistis, G.; Taylor, C.J. Phase studies and particle size analysis of oil-in-water phospholipid microemulsions. Int. J. Pharm., 1995, 116, 253-261.
48. Trotta, M.; Pattarino, F.; Grosa, G. Formation of lecithin-based microemulsions containing n-alkanol phosphocholines. Int. J. Pharm., 1998, 174, 253-259.
49. Sheikh, S.; Faiyaz, S.; Sushma, T.; Farhan, J.A.; Roop, K.K.; Mushir, A. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm., 2007, 66, 227-243.
50. Patil, P.; Joshi, P.; Paradkar, A. Effect of formulation variables on preparation and evaluation of gelled self-emulsifying drug delivery system of ketoprofen. AAPS Pharm. Sci. Tech., 2004, 5, 1-8.
51. Kim, H.J.; Yoon, K.A.; Hahn, M.; Park, E.S.; Chi, S.C. Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Dev. Ind. Pharm., 2000, 26, 523-529.